Adverse transfusion events in a public hospital in northern Minas Gerais
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/35959 |
Resumo: | This study analyzed indications and transfusion adverse events that occurred at Clemente Faria University Hospital, located in Montes Claros/MG. This was a cross-sectional, retrospective, quantitative and descriptive study. Data were collected from medical records, cross-testing sector records, and transfusion adverse events notification forms. The research was approved by the CEP of UNIMONTES. From 11/2018 to 06/2019, 1592 blood products were transfused at the HUCF, 54,6% packed red blood cells, 34,2% platelets, 7,9% fresh frozen plasma, and 3.3% cryoprecipitate. Among the packed red blood cells transfused, 5.4% were leukocyte-depleted, 6.9% were irradiated/deleukocyted, and 2.4% were leukocyte/phenotyped. Thirteen immediate adverse events were reported corresponding to 12.4/1000 transfusions performed. The classification of reactions was distributed into 8 non-hemolytic febrile reactions (mild), 2 allergic (mild), 1 TRALI- unlikely (severe), 1 transfusion-associated dyspnea- unlikely (moderate), and 1 other-related acute pain (mild). RBC concentrates were the most related adverse reactions (10/13), followed by platelets (3/10). The expected parameters as per the hemovigilance report (2016) define the average of 5 reactions/ 1000 transfusions performed. Published papers have demonstrated varied frequencies. No late adverse events were identified. Despite the existence of standardized procedures and evidence of periodic training, it is believed that there is underreporting of transfusion adverse events. We conclude that transfusion therapy requires well-defined training and procedures, in addition to hemovigilance and adverse event reporting. |
id |
UNIFEI_f357bf029ad0045905b9c88355d19fe0 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/35959 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
Adverse transfusion events in a public hospital in northern Minas Gerais Eventos adversos de transfusión en un hospital público del norte de Minas Gerais Eventos adversos transfusionais em um hospital público do norte de Minas Gerais TransfusionHemovigilanceQuality.TransfusiónHemovigilanciaCalidad.TransfusãoHemovigilânciaQualidade.This study analyzed indications and transfusion adverse events that occurred at Clemente Faria University Hospital, located in Montes Claros/MG. This was a cross-sectional, retrospective, quantitative and descriptive study. Data were collected from medical records, cross-testing sector records, and transfusion adverse events notification forms. The research was approved by the CEP of UNIMONTES. From 11/2018 to 06/2019, 1592 blood products were transfused at the HUCF, 54,6% packed red blood cells, 34,2% platelets, 7,9% fresh frozen plasma, and 3.3% cryoprecipitate. Among the packed red blood cells transfused, 5.4% were leukocyte-depleted, 6.9% were irradiated/deleukocyted, and 2.4% were leukocyte/phenotyped. Thirteen immediate adverse events were reported corresponding to 12.4/1000 transfusions performed. The classification of reactions was distributed into 8 non-hemolytic febrile reactions (mild), 2 allergic (mild), 1 TRALI- unlikely (severe), 1 transfusion-associated dyspnea- unlikely (moderate), and 1 other-related acute pain (mild). RBC concentrates were the most related adverse reactions (10/13), followed by platelets (3/10). The expected parameters as per the hemovigilance report (2016) define the average of 5 reactions/ 1000 transfusions performed. Published papers have demonstrated varied frequencies. No late adverse events were identified. Despite the existence of standardized procedures and evidence of periodic training, it is believed that there is underreporting of transfusion adverse events. We conclude that transfusion therapy requires well-defined training and procedures, in addition to hemovigilance and adverse event reporting.Este estudio analizó las indicaciones y los eventos adversos transfusionales ocurridos en el Hospital Universitario Clemente Faria, ubicado en Montes Claros/MG. Fue un estudio transversal, retrospectivo, cuantitativo y descriptivo. Los datos fueron recolectados de las historias clínicas, de los registros del sector de pruebas cruzadas y de los formularios de notificación de eventos adversos transfusionales. La investigación fue aprobada por el CEP de UNIMONTES. Del 11/2018 al 06/2019 se transfundieron 1592 hemoderivados en el HUCF, 54,6% glóbulos rojos empaquetados, 34,2% plaquetas, 7,9% plasma fresco congelado y 3,3% crioprecipitado. Entre los glóbulos rojos empaquetados transfundidos, el 5,4% estaban desprovistos de leucocitos, el 6,9% estaban irradiados/deleucocitados y el 2,4% estaban leucocitados/fenotipados. Se notificaron trece acontecimientos adversos inmediatos correspondientes a 12,4/1000 transfusiones realizadas. La clasificación de las reacciones se distribuyó en 8 reacciones febriles no hemolíticas (leves), 2 alérgicas (leves), 1 TRALI- improbable (grave), 1 disnea asociada a la transfusión- improbable (moderada), y 1 dolor agudo relacionado con otros (leve). Los concentrados de glóbulos rojos fueron las reacciones adversas más relacionadas (10/13), seguidas de las plaquetas (3/10). Los parámetros esperados según el informe de hemovigilancia (2016) definen la media de 5 reacciones/ 1000 transfusiones realizadas. Los trabajos publicados han demostrado frecuencias variadas. No se identificaron eventos adversos tardíos. A pesar de la existencia de procedimientos estandarizados y de la evidencia de formación periódica, se cree que existe una infranotificación de los eventos adversos transfusionales. Concluimos que la terapia transfusional requiere una formación y unos procedimientos bien definidos, además de la hemovigilancia y la notificación de eventos adversos.Este estudo analisou indicações e eventos adversos transfusionais que ocorreram no Hospital Universitário Clemente Faria, localizado em Montes Claros/MG. Foi realizado um estudo transversal, retrospectivo, quantitativo e descritivo. Foram coletados dados de prontuários, registros do setor de prova cruzada e ficha de notificação de eventos adversos transfusionais. A pesquisa teve a aprovação do CEP da UNIMONTES. No período de 11/2018 a 06/2019 foram transfundidos 1592 hemocomponentes no HUCF, concentrado de hemácias (54,6%), 545 plaquetas (34,2%), 125 plasma fresco congelado (7,9%) e 53 crioprecipitados (3,3%). Entre os concentrados de hemácias transfundidos, 5,4% eram desleucocitados, 6,9 % irradiados/desleucocitados e 2,4% desleucocitados/ fenotipados. Foram notificados 13 eventos adversos imediatos correspondendo a 12,3/1000 transfusões realizadas. A classificação das reações foi distribuída em oito reações febris não hemolíticas (leves), dois alérgicas (leve), um TRALI- improvável (grave), um dispneia associada à transfusão- improvável (moderada) e outras- dor aguda relacionada (leve). Os concentrados de hemácias foram os mais relacionados com as reações adversas (10/13) e a sequir as plaquetas (3/10). Os parâmetros esperados conforme relatório de hemovigilância (2016) define a média de cinco reações/ 1000 transfusões realizadas. Trabalhos publicados demonstraram frequências variadas. Não foram identificados eventos adversos tardios. Apesar da existência de procedimentos padronizados e evidência de treinamentos periódicos, acredita- se que haja subnotificação de eventos adversos transfusionais. Conclui-se que a terapêutica transfusional exige treinamentos e procedimentos bem definidos, além de hemovigilância e notificação de eventos adversos.Research, Society and Development2022-10-15info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3595910.33448/rsd-v11i13.35959Research, Society and Development; Vol. 11 No. 13; e569111335959Research, Society and Development; Vol. 11 Núm. 13; e569111335959Research, Society and Development; v. 11 n. 13; e5691113359592525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/35959/29991Copyright (c) 2022 Alessa Assis Guimarães Silvério ; Arthur Macedo Goulart Silva; Leandro de Freitas Teles ; Caroline Urias Rocha; José Wilson de Brito Sales; Tânia de Cássia Moreira Soares; José Alfreu Soares Júnior; Letícia Teixeira Guimarães; Elaine Veloso Rocha Uriashttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilvério , Alessa Assis Guimarães Silva, Arthur Macedo Goulart Teles , Leandro de Freitas Rocha, Caroline Urias Sales, José Wilson de Brito Soares, Tânia de Cássia Moreira Soares Júnior, José Alfreu Guimarães, Letícia Teixeira Urias, Elaine Veloso Rocha 2022-10-17T13:43:46Zoai:ojs.pkp.sfu.ca:article/35959Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:50:40.789097Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
Adverse transfusion events in a public hospital in northern Minas Gerais Eventos adversos de transfusión en un hospital público del norte de Minas Gerais Eventos adversos transfusionais em um hospital público do norte de Minas Gerais |
title |
Adverse transfusion events in a public hospital in northern Minas Gerais |
spellingShingle |
Adverse transfusion events in a public hospital in northern Minas Gerais Silvério , Alessa Assis Guimarães Transfusion Hemovigilance Quality. Transfusión Hemovigilancia Calidad. Transfusão Hemovigilância Qualidade. |
title_short |
Adverse transfusion events in a public hospital in northern Minas Gerais |
title_full |
Adverse transfusion events in a public hospital in northern Minas Gerais |
title_fullStr |
Adverse transfusion events in a public hospital in northern Minas Gerais |
title_full_unstemmed |
Adverse transfusion events in a public hospital in northern Minas Gerais |
title_sort |
Adverse transfusion events in a public hospital in northern Minas Gerais |
author |
Silvério , Alessa Assis Guimarães |
author_facet |
Silvério , Alessa Assis Guimarães Silva, Arthur Macedo Goulart Teles , Leandro de Freitas Rocha, Caroline Urias Sales, José Wilson de Brito Soares, Tânia de Cássia Moreira Soares Júnior, José Alfreu Guimarães, Letícia Teixeira Urias, Elaine Veloso Rocha |
author_role |
author |
author2 |
Silva, Arthur Macedo Goulart Teles , Leandro de Freitas Rocha, Caroline Urias Sales, José Wilson de Brito Soares, Tânia de Cássia Moreira Soares Júnior, José Alfreu Guimarães, Letícia Teixeira Urias, Elaine Veloso Rocha |
author2_role |
author author author author author author author author |
dc.contributor.author.fl_str_mv |
Silvério , Alessa Assis Guimarães Silva, Arthur Macedo Goulart Teles , Leandro de Freitas Rocha, Caroline Urias Sales, José Wilson de Brito Soares, Tânia de Cássia Moreira Soares Júnior, José Alfreu Guimarães, Letícia Teixeira Urias, Elaine Veloso Rocha |
dc.subject.por.fl_str_mv |
Transfusion Hemovigilance Quality. Transfusión Hemovigilancia Calidad. Transfusão Hemovigilância Qualidade. |
topic |
Transfusion Hemovigilance Quality. Transfusión Hemovigilancia Calidad. Transfusão Hemovigilância Qualidade. |
description |
This study analyzed indications and transfusion adverse events that occurred at Clemente Faria University Hospital, located in Montes Claros/MG. This was a cross-sectional, retrospective, quantitative and descriptive study. Data were collected from medical records, cross-testing sector records, and transfusion adverse events notification forms. The research was approved by the CEP of UNIMONTES. From 11/2018 to 06/2019, 1592 blood products were transfused at the HUCF, 54,6% packed red blood cells, 34,2% platelets, 7,9% fresh frozen plasma, and 3.3% cryoprecipitate. Among the packed red blood cells transfused, 5.4% were leukocyte-depleted, 6.9% were irradiated/deleukocyted, and 2.4% were leukocyte/phenotyped. Thirteen immediate adverse events were reported corresponding to 12.4/1000 transfusions performed. The classification of reactions was distributed into 8 non-hemolytic febrile reactions (mild), 2 allergic (mild), 1 TRALI- unlikely (severe), 1 transfusion-associated dyspnea- unlikely (moderate), and 1 other-related acute pain (mild). RBC concentrates were the most related adverse reactions (10/13), followed by platelets (3/10). The expected parameters as per the hemovigilance report (2016) define the average of 5 reactions/ 1000 transfusions performed. Published papers have demonstrated varied frequencies. No late adverse events were identified. Despite the existence of standardized procedures and evidence of periodic training, it is believed that there is underreporting of transfusion adverse events. We conclude that transfusion therapy requires well-defined training and procedures, in addition to hemovigilance and adverse event reporting. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-10-15 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/35959 10.33448/rsd-v11i13.35959 |
url |
https://rsdjournal.org/index.php/rsd/article/view/35959 |
identifier_str_mv |
10.33448/rsd-v11i13.35959 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/35959/29991 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 13; e569111335959 Research, Society and Development; Vol. 11 Núm. 13; e569111335959 Research, Society and Development; v. 11 n. 13; e569111335959 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052725902442496 |